0001236031-17-000009.txt : 20170630
0001236031-17-000009.hdr.sgml : 20170630
20170630165021
ACCESSION NUMBER: 0001236031-17-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170629
FILED AS OF DATE: 20170630
DATE AS OF CHANGE: 20170630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZIMMERMAN DANIEL H
CENTRAL INDEX KEY: 0001236028
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 17942825
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-06-29
0
0000725363
CEL SCI CORP
cvm
0001236028
ZIMMERMAN DANIEL H
0
1
0
0
Senior Vice President
Options
1.87
2017-06-29
4
A
0
6000
0.01
A
2027-06-28
Common Stock
6000
28968
D
The stock options vest in three (3) equal annual installments commencing one year after the grant date.
Daniel Zimmerman
2017-06-30